Selective serotonin-reuptake inhibitors: an update PS Masand, S Gupta Harvard review of psychiatry 7 (2), 69-84, 1999 | 288 | 1999 |
Olanzapine in the treatment of delirium A Sipahimalani, PS Masand Psychosomatics 39 (5), 422-430, 1998 | 286 | 1998 |
Addressing the side effects of contemporary antidepressant drugs: a comprehensive review SM Wang, C Han, WM Bahk, SJ Lee, AA Patkar, PS Masand, CU Pae Chonnam medical journal 54 (2), 101, 2018 | 284 | 2018 |
Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise DM Marks, MJ Shah, AA Patkar, PS Masand, GY Park, CU Pae Current neuropharmacology 7 (4), 331-336, 2009 | 280 | 2009 |
Tolerability and adherence issues in antidepressant therapy PS Masand Clinical therapeutics 25 (8), 2289-2304, 2003 | 276 | 2003 |
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine PS Masand, S Gupta Annals of Clinical Psychiatry 14, 175-182, 2002 | 250 | 2002 |
Comorbidity of irritable bowel syndrome in psychiatric patients: a review A Garakani, T Win, S Virk, S Gupta, D Kaplan, PS Masand American journal of therapeutics 10 (1), 61-67, 2003 | 216 | 2003 |
Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants SY Lee, SJ Lee, C Han, AA Patkar, PS Masand, CU Pae Progress in Neuro-Psychopharmacology and Biological Psychiatry 46, 224-235, 2013 | 215 | 2013 |
Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review PS Masand, M Roca, MS Turner, JM Kane Primary care companion to the Journal of clinical psychiatry 11 (4), 147, 2009 | 211 | 2009 |
The role of atypical antipsychotics in the treatment of delirium TL Schwartz, PS Masand Psychosomatics 43 (3), 171-174, 2002 | 200 | 2002 |
Psychometric properties of the Patient Health Questionnaire–15 (PHQ–15) for measuring the somatic symptoms of psychiatric outpatients C Han, CU Pae, AA Patkar, PS Masand, KW Kim, SH Joe, IK Jung Psychosomatics 50 (6), 580-585, 2009 | 183 | 2009 |
Use of risperidone in delirium A Sipahimalani, PS Masand Annals of Clinical Psychiatry 9 (2), 105-107, 1997 | 173 | 1997 |
Psychostimulants for depression in hospitalized cancer patients J Olin, P Masand Psychosomatics 37 (1), 57-62, 1996 | 168 | 1996 |
Use of stimulants in the medically ill PS Masand, GE Tesar Psychiatric Clinics of North America 19 (3), 515-547, 1996 | 163 | 1996 |
Major depression and irritable bowel syndrome: is there a relationship? PS Masand, DS Kaplan, S Gupta, AN Bhandary, GS Nasra, MD Kline, ... The Journal of clinical psychiatry 56 (8), 363-367, 1995 | 160 | 1995 |
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression AA Patkar, PS Masand, CU Pae, K Peindl, C Hooper-Wood, P Mannelli, ... Journal of clinical psychopharmacology 26 (6), 653-656, 2006 | 154 | 2006 |
Side effects of antipsychotics in the elderly PS Masand Journal of Clinical Psychiatry 61 (4), 43-51, 2000 | 154 | 2000 |
The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis RS McIntyre, IP Carvalho, LMW Lui, A Majeed, PS Masand, H Gill, ... Journal of affective disorders 276, 576-584, 2020 | 151 | 2020 |
A randomized, controlled, trial of controlled release paroxetine in fibromyalgia AA Patkar, PS Masand, S Krulewicz, P Mannelli, K Peindl, KL Beebe, ... The American Journal of Medicine 120 (5), 448-454, 2007 | 144 | 2007 |
Treatment of delirium with quetiapine TL Schwartz, PS Masand Primary care companion to the Journal of clinical psychiatry 2 (1), 10, 2000 | 136 | 2000 |